Literature DB >> 332070

Bactericidal activity of the combinations of gentamicin with clindamycin or chloramphenicol against species of Escherichia coli and Bacteroides fragilis.

J Klastersky, M Husson.   

Abstract

The bactericidal activity of clindamycin, chloramphenicol, and gentamicin alone and of gentamicin plus clindamycin and gentamicin plus chloramphenicol was studied on 8 strains of Escherichia coli and 10 strains of Bacteroides fragilis isolated from clinical material. Gentamicin did not interfere with the activity of clindamycin or chloramphenicol against B. fragilis. The activity of gentamicin against E. coli was not influenced by clindamycin, but chloramphenicol suppressed the rapid bactericidal activity of gentamicin in seven out of eight strains of E. coli examined.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 332070      PMCID： PMC429876          DOI： 10.1128/AAC.12.2.135

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  9 in total

1.  Bactericidal activity of combinations of gentamicin with penicillin or clindamycin against Streptococcus mutans.

Authors:  R J Snyder; C J Wilkowske; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1975-03       Impact factor: 5.191

2.  Activity of combinations of antimicrobial agents against Bacteroides fragilis.

Authors:  D F Busch; V L Sutter; S M Finegold
Journal:  J Infect Dis       Date:  1976-03       Impact factor: 5.226

3.  Treatment of pneumococcic meningitis with penicillin compared with penicillin plus aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin.

Authors:  M H LEPPER; H F DOWLING
Journal:  AMA Arch Intern Med       Date:  1951-10

4.  Clinical significance of in vitro synergism between antibiotics in gram-negative infections.

Authors:  J Klastersky; R Cappel; D Daneau
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

5.  In vivo antagonism between gentamicin and chloramphenicol in neutropenic mice.

Authors:  M A Sande; J W Overton
Journal:  J Infect Dis       Date:  1973-08       Impact factor: 5.226

6.  Interaction of clindamycin and gentamicin in vitro.

Authors:  R J Fass; C A Rotilie; R B Prior
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

7.  Bactericidal activity of combinations of penicillin or clindamycin with gentamicin or streptomycin against species of viridans streptococci.

Authors:  R Duperval; N J Bill; J E Geraci; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1975-12       Impact factor: 5.191

8.  Susceptibilities of gram-negative bacteria to combinations of antimicrobial agents in vitro.

Authors:  B Leng; B R Meyers; S Z Hirschman; G T Keusch
Journal:  Antimicrob Agents Chemother       Date:  1975-08       Impact factor: 5.191

9.  Experimental intra-abdominal abscesses in rats: development of an experimental model.

Authors:  W M Weinstein; A B Onderdonk; J G Bartlett; S L Gorbach
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441
  9 in total
  4 in total

Review 1.  Chloramphenicol in the 1980s.

Authors:  I Shalit; M I Marks
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

2.  Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.

Authors:  I Brook; J C Coolbaugh; R I Walker; E Weiss
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

3.  Effect of growth phase on the bactericidal action of chloramphenicol against Haemophilus influenzae type b and Escherichia coli K-1.

Authors:  W E Feldman; N S Manning
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

4.  A Multidisciplinary Study to Evaluate the Anti-quorum Sensing Ability of Phyto-compounds in Ruellia patula Jacq.

Authors:  P Chemmugil; Ptv Lakshmi; A Annamalai
Journal:  Avicenna J Med Biotechnol       Date:  2019 Jan-Mar
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.